Ghana’s emerging industrial hemp and regulated medical cannabis sectors were presented at the Japan International Hemp Expo (JIHE) 2026, a two-day event held at the House of OMOTESANDO in Tokyo. Dr Mark G. Darko, President of the Chamber of Cannabis Industry (CannaCham), was the only African speaker at the expo.
The event brought together industry players, researchers, entrepreneurs and other stakeholders to discuss industrial hemp, medical cannabis and cannabidiol (CBD), including regulatory frameworks, investment opportunities and emerging markets.
Speaking on the theme “Latest Trends in the CBD and Cannabis Industry Overseas and Their Impact on the Japanese Market,” Dr Darko examined Ghana’s regulatory framework for industrial hemp and regulated medical cannabis. He also outlined investment opportunities in cultivation, processing, extraction and pharmaceutical applications, and stressed the importance of scientific research, quality assurance and regulatory compliance in developing the sector.
The Chamber said its participation allowed it to engage international stakeholders and explore possible cooperation in the hemp and CBD industries. Dr Darko noted that platforms such as JIHE give Ghana a chance to form industry partnerships and contribute to discussions on the global cannabis market.
Ghana’s regulatory approach is based on the Narcotics Control Commission (Amendment) Act, 2023 (Act 1100). The Act provides a framework for licensing the cultivation of cannabis with a tetrahydrocannabinol (THC) content not exceeding 0.3 per cent for industrial and medicinal purposes. It distinguishes this regulated cultivation from recreational cannabis, which remains prohibited. The licensing regime is meant to support industrial hemp and medicinal cannabis activities under regulatory supervision.
The Chamber said it remains committed to supporting the development of a regulated cannabis industry in Ghana and strengthening the country’s engagement with international industry stakeholders.